Status:
COMPLETED
Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
Navrongo Health Research Centre, Navrongo, Ghana.
Kintampo Health Research Centre, Ghana
Conditions:
Anaemia
Malaria
Eligibility:
All Genders
2-24 years
Phase:
NA
Brief Summary
Evaluation of the safety and effectiveness of malaria intermittent chemotherapy and iron supplementation delivered through Expanded Programme on Immunisation vaccination clinics.
Detailed Description
Anaemia is one of the main disease burdens of children in developing countries. Severe anaemia is often fatal, while moderate anaemia leads to growth and cognitive disorders. The incidence of anaemia ...
Eligibility Criteria
Inclusion
- All infants living in study clusters without a history of allergy to sulfadoxine-pyrimethamine were eligible for enrollment in the study.
Exclusion
- History of allergy to sulfadoxine-pyrimethamine.
Key Trial Info
Start Date :
September 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2004
Estimated Enrollment :
2485 Patients enrolled
Trial Details
Trial ID
NCT00857077
Start Date
September 1 2000
End Date
June 1 2004
Last Update
January 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Navrongo Health Research Centre
Navrongo, Upper East Region, Ghana